Sonnet BioTherapeutics Holdings, Inc. — Form D

Sonnet BioTherapeutics Holdings, Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-18. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Restaurants.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Michael CarrollDirectorRichmond, VA
Keith JohnsonDirectorWilson, WY
Paul MoskowitzDirectorBoston, MA
Russell PageDirectorCHARLOTTE, NC
Michael PruittDirectorHauppauge, NY
Eric LedererExecutive OfficerCHARLOTTE, NC
Michael PruittExecutive OfficerHauppauge, NY
John K CiniExecutive OfficerPrinceton, NJ
Albert K DyrnessDirectorPrinceton, NJ
Nailesh K BhattDirectorPrinceton, NJ
Pankaj MohanDirectorPrinceton, NJ
Pankaj MohanExecutive OfficerPrinceton, NJ
Donald K GriffithDirectorPrinceton, NJ
Susan K DexterExecutive OfficerPrinceton, NJ
Richard K KennyExecutive OfficerPrinceton, NJ
Raghu K RaoDirectorPrinceton, NJ
Jay CrossExecutive OfficerSouth San Francisco, CA
Lori K McNeilDirectorPrinceton, NJ
Keith J JohnsonDirectorCharlotte, NC
Paul MoskowitzExecutive OfficerBoston, MA
GREGORY E KRAUTDirectorWESTPORT, CT
Russell J PageDirectorCharlotte, NC
Neil C KieferDirectorCharlotte, NC
Larry S SpitcaufskyExecutive OfficerCharlotte, NC
David P OsbornDirectorCharlotte, NC

Other filings by this issuer (11)

FiledFormOfferingSold
2024-12-23D$3.9M$3.9M
2023-07-17D$2.3M$2.3M
2022-08-19D$2.3M$2.3M
2018-05-16D$1.4M$1.4M
2017-05-11D$6.0M$6.0M
2015-01-16D$1.1M$1.1M
2013-11-20D$800K$800K
2013-10-22D$2.5M$2.5M
2013-10-15D
2013-08-13D$3.0M$3.0M
2011-11-30D$1.1M$1.1M

More